NCT02899455View on ClinicalTrials.gov

Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia

PHASE3CompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
HypertensionHyperlipidemia
Interventions
DRUG

HGP0904

DRUG

HGP0608

DRUG

HGP0816

DRUG

HGP0904 Placebo

DRUG

HGP0816 Placebo

Trial Locations (1)

Unknown

23 institutions including Samsung Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT02899455 - Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia | Biotech Hunter | Biotech Hunter